Clough Capital Partners L P Gossamer Bio, Inc. Transaction History

Clough Capital Partners L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $1.16 Million - $2.11 Million	-159,725 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $2.39 Million - $2.91 Million	-298,909 Reduced 65.17%	159,725 $1.3 Million
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $10,356 - $13,128	-1,200 Reduced 0.26%	458,634 $4.24 Million
Q4 2019 Feb 14, 2020	SELL	$14.82 - $26.79 $472,758 - $854,601	-31,900 Reduced 6.49%	459,834 $7.19 Million
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $669,636 - $939,246	41,800 Added 9.29%	491,734 $8.26 Million
Q2 2019 Aug 14, 2019	SELL	$16.12 - $22.89 $488,436 - $693,567	-30,300 Reduced 6.31%	449,934 $9.92 Million
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $8.44 Million - $11.5 Million	480,234 New	480,234 $10.2 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $65.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.